scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company specializing in optimizing infused therapies, announced that CEO John Tucker will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company specializing in optimizing infused therapies, announced that CEO John Tucker will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022, in New York. His presentation will be available for on-demand viewing starting September 12 at 7:00 am ET. Attendees can also schedule virtual one-on-one meetings with Tucker during the conference. The replay will be accessible in the Investor Relations section of scPharmaceuticals' website.
Details
News Market Reaction – SCPH
The recorded move for SCPH in the trading session of this news was -0.85%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced today that John Tucker, president & chief executive officer, is scheduled to present virtually at the H.C. Wainwright 24th Annual Global Investment Conference, which is being held in a hybrid format, in-person and virtually, from September 12-14 in New York.
Mr. Tucker’s presentation will be available for on-demand viewing beginning at 7:00am ET on Monday, September 12. In addition, Mr. Tucker is available to host virtual one-on-one meetings with interested conference participants for the duration of the conference.
A replay of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com
Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.